Nuria Garcia-Barbera
Overview
Explore the profile of Nuria Garcia-Barbera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Los Reyes-Garcia A, Rivera-Caravaca J, Zapata-Martinez L, Aguila S, Veliz-Martinez A, Garcia-Barbera N, et al.
J Pers Med
. 2022 Jul;
12(7).
PMID: 35887682
Studies on older patients have established notable conceptual changes in the etiopathogenesis of acute coronary syndrome (ACS), but little is known about this disease in young patients (<45 years). Of...
2.
Barrachina M, Izquierdo I, Hermida-Nogueira L, Moran L, Perez A, Arroyo A, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33804911
Background: Clinical management of ischemic events and prevention of vascular disease is based on antiplatelet drugs. Given the relevance of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) as a candidate target in thrombosis, the...
3.
Fernandez-Perez M, Aguila S, Reguilon-Gallego L, de Los Reyes-Garcia A, Minano A, Bravo-Perez C, et al.
Clin Transl Med
. 2021 Jan;
11(1):e268.
PMID: 33463053
No abstract available.
4.
Rivera-Caravaca J, Teruel-Montoya R, Roldan V, Cifuentes-Riquelme R, Crespo-Matas J, de Los Reyes-Garcia A, et al.
J Clin Med
. 2020 Nov;
9(11).
PMID: 33198388
. Atrial fibrillation (AF) increases the risk for stroke but also for non-stroke major adverse cardiovascular events (MACE). The 2MACE score was recently proposed to predict these events. Since the...
5.
Lozano M, Garabet L, Fernandez-Perez M, de Los Reyes-Garcia A, Diaz-Lozano P, Garcia-Barbera N, et al.
Platelets
. 2019 Nov;
31(7):906-912.
PMID: 31762368
No biological predictors for the increased risk of thrombosis in patients with immune thrombocytopenia (ITP) have been identified. The aim of the study was to investigate platelet and neutrophil activation...
6.
Vallejo F, Yuste J, Teruel-Montoya R, Luengo-Gil G, Bohdan N, Espin S, et al.
Thromb Res
. 2019 Nov;
183:80-85.
PMID: 31671376
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease in which patients are at increased risk of thrombosis. The mechanisms underlying the associated thrombosis risk are still poorly understood, although...
7.
de Los Reyes-Garcia A, Aroca A, Arroyo A, Garcia-Barbera N, Vicente V, Gonzalez-Conejero R, et al.
Biomed Rep
. 2019 Mar;
10(3):195-201.
PMID: 30906549
Neutrophil extracellular traps (NETs) represent an important link between inflammation and thrombosis. Here, the present study aimed to investigate the influence of the NET components, DNA and histone H4, on...
8.
Teruel-Montoya R, Luengo-Gil G, Vallejo F, Yuste J, Bohdan N, Garcia-Barbera N, et al.
Sci Rep
. 2019 Mar;
9(1):3611.
PMID: 30837665
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a clonal disease of blood cells caused by the lack of glycosyl phosphatidyl inositol anchored proteins bound to the cell membrane. In consequence, erythrocytes lead...
9.
Del Monte A, Arroyo A, Andres-Manzano M, Garcia-Barbera N, Caleprico M, Vicente V, et al.
PLoS One
. 2018 Jun;
13(6):e0198932.
PMID: 29902229
Background: Atherosclerosis involves activation of the IRAK1/TRAF6/NF-κB inflammatory cascade, which is negatively regulated by miR146a. Previous studies showed that the TT genotype of rs2431697, located near the miR-146a gene, drives...
10.
Arroyo A, de Los Reyes-Garcia A, Rivera-Caravaca J, Valledor P, Garcia-Barbera N, Roldan V, et al.
Arterioscler Thromb Vasc Biol
. 2018 Feb;
38(4):892-902.
PMID: 29437577
Objective: Atrial fibrillation (AF) patients experience adverse cardiovascular events (ACEs) despite anticoagulant therapy. We reported that rs2431697 of miR-146a, a negative regulator of inflammation, predicts ACEs in patients with AF....